Khaitan & Co Advised Viatris Inc. On The Sale Of Shares In Biocon Biologics Limited
Khaitan & Co advised Viatris Inc. on the sale of shares in Biocon Biologics Limited
The leading law firm in India, Khaitan & Co advised Viatris Inc., a global pharmaceutical company, on its proposed sale of shares held in Biocon Biologics Limited (“BBL”) for cash and a swap of shares with Biocon Limited (“BL”), through a preferential allotment by BL. Biocon will acquire the stake held by Mylan Inc. (“Viatris”) for a total consideration of USD 815 million, of which USD 400 million will be payable in cash and USD 415 million through a share swap of BL shares. The firm advised Viatris on Indian aspects of structuring and transaction documentation.
The Khaitan & Co team was led by Rabindra Jhunjhunwala (Partner), Abhishek Dadoo (Partner), Aman Anand (Principal Associate), Gaurang Mansinghka (Senior Associate) and Nitya Saxena (Associate), with assistance from:
The Banking aspects Rajeev Vidhani (Partner) and Krishnendu Sen (Counsel)
The Anti-trust aspects Anisha Chand (Partner) and Yatharth Vardhan Singh (Senior Associate)
The Taxation aspects Ritu Shaktawat (Partner) and Husain Bohra (Senior Associate)
The Capital markets aspects Aditya Cheriyan (Partner) and Chirayu Chandani (Partner)
Click to know more about Khaitan & Co
If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.
